Page 4 - Consciousness Research At Johns Hopkins University News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consciousness research at johns hopkins university. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consciousness Research At Johns Hopkins University Today - Breaking & Trending Today

Psychedelic treatment may offer a cure for depression and other mental illnesses


Print this article
Relief from various mental illnesses may in the not-too-distant future come from a surprising source: psychedelics.
The substance psilocybin is found in various types of mushrooms. The Center for Psychedelic and Consciousness Research at Johns Hopkins University is conducting extensive research into it as a treatment for mental illness.
“The psychedelic research that we’ve been doing has been going on for nearly two decades,” said Matthew Johnson, a professor of psychiatry and behavioral sciences at the center. “I’ve been conducting this research since 2004.”
In 2008, Johnson helped resurrect psychedelic research by publishing safety guidelines. Since then, he has conducted studies on how psilocybin can treat nicotine addiction and is currently working on research into whether it can treat opioid addiction and post-traumatic stress disorder. Other researchers at the center are focusing on psilocybin as a treatment for depression. ....

Johns Hopkins , Timothy Leary , Matthew Johnson , Consciousness Research At Johns Hopkins University , Drug Administration , Consciousness Research , Johns Hopkins University , ஜான்ஸ் ஹாப்கின்ஸ் , தீமோத்தேயு லீரி , மேத்யூ ஜான்சன் , உணர்வு ஆராய்ச்சி இல் ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , உணர்வு ஆராய்ச்சி , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் ,

Psychedelic drug worked for depression as well as common antidepressant, small trial finds


Psychedelic drug worked for depression as well as common antidepressant, small trial finds
Kaitlin Sullivan
© Provided by NBC News
A couple of doses of a psychedelic drug may treat depression as well as one of the most commonly prescribed antidepressants, a small and short study published Wednesday shows.
A Phase 2 clinical trial, conducted by researchers in London, was the first randomized trial to compare therapeutic doses of psilocybin the psychedelic compound found in so-called magic mushrooms with a daily medication. The results were released in The New England Journal of Medicine.
This is huge because it s showing that psilocybin is at least as good and probably better than the gold standard treatment for depression, said Roland Griffiths, director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University, who was not involved in the study. ....

United States , City Of , United Kingdom , Robin Carhart Harris , Alan Davis , Roland Griffiths , Centers For Disease , Johns Hopkins University , Consciousness Research At Johns Hopkins University , Ohio State University , New England Journal , Consciousness Research , Psychedelic Research , Imperial College , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ராபின் கார்ஹார்ட் ஹாரிஸ் , ஆலன் டேவிஸ் , ரோலண்ட் கிரிஃபித்ஸ் , மையங்கள் க்கு நோய் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , உணர்வு ஆராய்ச்சி இல் ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , ஓஹியோ நிலை பல்கலைக்கழகம் , புதியது இங்கிலாந்து இதழ் ,